Richter, Holly E., J. E. Jelovsek, P. Iyer, R. G. Rogers, I. Meyer, D. K. Newman, M. S. Bradley, et al. “Characteristics Associated With Clinically Important Treatment Responses in Women Undergoing Nonsurgical Therapy for Fecal Incontinence.” Am J Gastroenterol 115, no. 1 (January 2020): 115–27. https://doi.org/10.14309/ajg.0000000000000482.
John E Jelovsek, MD
Dr. Jelovsek is the Vice Chair of Education and the Director of Data Science for Women’s Health in Department of Obstetrics & Gynecology (OBGYN) at Duke University. He is Board Certified in OBGYN by the American Board of OBGYN and Board Certified in Female Pelvic Medicine & Reconstructive Surgery by the American Board of OBGYN and American Board of Urology. He currently practices Female Pelvic Medicine and Reconstructive Surgery (FPMRS). He has expertise in the development and validation of “individualized” patient-centered prediction tools to improve patient and clinician decision-making around development and possible prevention of pelvic floor disorders after childbirth, predicting the risk of de novo stress urinary incontinence after surgery for pelvic organ prolapse, wound infection after Cesarean delivery, transfusion during gynecologic surgery and efficacy and risk of undergoing pelvic organ prolapse surgery. He currently serves as co-principal investigator in the NIDDK Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) (U01DK097780-05) where he is involved in studies using unsupervised learning approaches such as clustering of lower urinary tract phenotypes. He also serves as a mentor in the NIDDK Duke KURe Program (K12DK100024) and NICHD AUGS/DUKE UrogynCREST program (R25HD094667). As an investigator in the NICHD Pelvic Floor Disorders Network, he was principle investigator on the CAPABLe trial (PMID: 31320277), one of the largest multi-center trials for fecal incontinence in the Pelvic Floor Disorders Network studying anal exercises with biofeedback and loperamide for the treatment of fecal incontinence. He was also the principle investigator of the E-OPTIMAL study (PMID: 29677302), describing the long-term follow up sacrospinous ligament fixation compared to uterosacral ligament suspension for apical vaginal prolapse.
Education and Training
- M.S.D.S., Northwestern University, 2019
- M.M.Ed., University of Dundee (United Kingdom), 2012
- M.D., East Tennessee State University James H. Quillen College of Medicine, 1999
Selected Grants and Awards
- Advancing the Measurement and Classification of Lower Urinary Tract Dysfunction
- AUGS/DUKE Urogynecology Clinical Research Educational Scientist Training (UrogynCREST) Program
- Duke KURe Program
- Predicting Urinary Continence Status with Sacral Neuromodulation and Botulinum Toxin Treatments
- A Prediction Model and Electronic Calculator for Risk of Obstetric Anal Sphincter Injuries
Brubaker, Linda, J Eric Jelovsek, Emily S. Lukacz, Sunil Balgobin, Alicia Ballard, Alison C. Weidner, Marie G. Gantz, Ryan Whitworth, Donna Mazloomdoost, and Donna Eunice Kennedy Shriver National Institute of Child Health and Human Development Pelvic Floor Disorders Network. “Recruitment and retention: A randomized controlled trial of video-enhanced versus standard consent processes within the E-OPTIMAL study.” Clin Trials 16, no. 5 (October 2019): 481–89. https://doi.org/10.1177/1740774519865541.
Bretschneider, C. E., X. Ji, and J. E. Jelovsek. “A MODEL TO PREDICT POSTOPERATIVE URINARY RETENTION AFTER UROGYNECOLOGIC SURGERY.” In International Urogynecology Journal, 30:S126–S126. SPRINGER LONDON LTD, 2019.
Jelovsek, J Eric, Alayne D. Markland, William E. Whitehead, Matthew D. Barber, Diane K. Newman, Rebecca G. Rogers, Keisha Dyer, et al. “Controlling faecal incontinence in women by performing anal exercises with biofeedback or loperamide: a randomised clinical trial.” Lancet Gastroenterol Hepatol 4, no. 9 (September 2019): 698–710. https://doi.org/10.1016/S2468-1253(19)30193-1.
Markland, A. D., M. F. Ackenbom, B. Carper, J. E. Jelovsek, S. Menefee, R. G. Rogers, V. W. Sung, et al. “FURTHER VALIDATION OF DIGITAL RECTAL EXAMINATION AND ANORECTAL MANOMETRY MEASURES TO PATIENT-REPORTED OUTCOMES AMONG WOMEN WITH FECAL INCONTINENCE.” In International Urogynecology Journal, 30:S140–41. SPRINGER LONDON LTD, 2019.
Liu, Alice B., Qian Liu, Claire C. Yang, James W. Griffith, Abigail R. Smith, Margaret E. Helmuth, H Henry Lai, et al. “Patient Characteristics Associated with More Bother from Lower Urinary Tract Symptoms.” J Urol 202, no. 3 (September 2019): 585–91. https://doi.org/10.1097/JU.0000000000000324.
Jakus-Waldman, S., L. Brubaker, D. Mazloomdoost, J. Schaffer, J. E. Jelovsek, D. R. Ellington, R. Whitworth, and M. G. Gantz. “RISK FACTORS FOR WORSENING OUTCOMES 5 YEARS AFTER VAGINAL PROLAPSE REPAIR.” In International Urogynecology Journal, 30:S34–35. SPRINGER LONDON LTD, 2019.
Cella, David, Abigail R. Smith, James W. Griffith, Kathryn E. Flynn, Catherine S. Bradley, Brenda W. Gillespie, Ziya Kirkali, et al. “A new outcome measure for LUTS: Symptoms of Lower Urinary Tract Dysfunction Research Network Symptom Index-29 (LURN SI-29) questionnaire.” Neurourol Urodyn 38, no. 6 (August 2019): 1751–59. https://doi.org/10.1002/nau.24067.